Role of Oral Antioxidant Supplementation in the Current Management of Diabetic Retinopathy
Por:
Alfonso-Muñoz EA, Burggraaf-Sánchez de Las Matas R, Mataix Boronat J, Molina Martín JC and Desco C
Publicada:
1 abr 2021
Ahead of Print:
13 abr 2021
Resumen:
Oxidative stress has been postulated as an underlying pathophysiologic mechanism of diabetic retinopathy (DR), the main cause of avoidable blindness in working-aged people. This review addressed the current daily clinical practice of DR and the role of antioxidants in this practice. A systematic review of the studies on antioxidant supplementation in DR patients was presented. Fifteen studies accomplished the inclusion criteria. The analysis of these studies concluded that antioxidant supplementation has a IIB level of recommendation in adult Type 1 and Type 2 diabetes mellitus subjects without retinopathy or mild-to-moderate nonproliferative DR without diabetic macular oedema as a complementary therapy together with standard medical care.
Filiaciones:
:
FISABIO-Oftalmología Médica (FOM), Vitreoretinal Unit, 46015 Valencia, Spain
:
Servicio de Oftalmología, Hospital General Universitario de Castellón, 12004 Castellón, Spain
:
FISABIO-Oftalmología Médica (FOM), Vitreoretinal Unit, 46015 Valencia, Spain
:
Servicio de Oftalmología, Hospital Universitario San Juan, 03550 Alicante, Spain
:
FISABIO-Oftalmología Médica (FOM), Vitreoretinal Unit, 46015 Valencia, Spain
Green Published, gold
|